Notice NOT-MH-17-027 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-028 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-026 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-024 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-025 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-020 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-17-242 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.

Funding Opportunity PAR-17-250 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.

Funding Opportunity PAR-17-244 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for collaborative R01 projects from multi-disciplinary teams to expand, improve, or transform the reliability and utility of mammalian cancer and tumor models for translational research. For a linked set of collaborative R01s, each site has its own Program Director(s)/Principal Investigator(s), and the program provides a mechanism for cross-site coordination and communication. Collaborative studies are appropriate to address translational modeling research questions beyond the capacity of a single-site investigation, particularly to accommodate collaborations among sites with diverse expertise, perspectives, and contributions.

Funding Opportunity RFA-AG-18-004 from the NIH Guide for Grants and Contracts. This FOA invites applications from qualified institutions to create or continue Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (CC). The RCMAR Program aims to enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in aging research. RCMARs focus on priority areas of social, behavioral, and economic research on the processes of aging at the individual or societal level. The program supports research at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational, with the goal to improve the health, well-being, function, and independence of older Americans. The new cycle of RCMARs will expand the scientific scope of the program to encourage transdisciplinary social and behavioral science research on any theme addressed in the National Institute on Aging Strategic Plan, and will include a new cohort of RCMARs focused on behavioral and social science related to Alzheimer's disease and related dementias (ADRD). Consistent with the longstanding focus of the RCMAR program on minority aging research, all centers are also expected to offer mentoring in health disparities and minority aging issues as a major component of their investigator development programs, thereby enhancing the potential impact of research supported by the program on all sectors of our aging society. The RCMAR CC will facilitate and coordinate trans-RCMAR activities. The CC will work closely with the NIA Program Officer and, in coordination with all RCMAR sites, be responsive to requests generated by key RCMAR site personnel, NIA, NIH, the scientific community, and the general public.

Funding Opportunity RFA-AG-18-002 from the NIH Guide for Grants and Contracts. The National Institute on Aging (NIA) invites applications from qualified institutions for the creation of Resource Centers for Minority Aging Research (RCMARs) with a focus on behavioral or social science research related to Alzheimers disease and related dementias (ADRD). The primary purpose of this FOA is (1) to support centers that will enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in ADRD-relevant research in a selected area of scientific focus, and (2) to develop infrastructure to promote advances in this area and increase the number of researchers focused on the health and well-being of minority elders. RCMARs focus on priority areas of social, behavioral, and economic research on the processes of aging at the individual or societal level. The program supports research at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational, with the goal to improve the health, well-being, function, and independence of older Americans. This new cycle of RCMARs will expand the scientific scope of the program to include a subset of centers focused on priority areas of social and behavioral science related to Alzheimers disease, including research on the epidemiology of ADRD, preventive interventions for ADRD, and the formal and informal care challenges of individuals with ADRD and their family members. Consistent with the longstanding focus of the RCMAR program on minority aging research, all centers are also expected to offer mentoring in health disparities and minority aging issues as a major component of their research education programs, thereby enhancing the potential impact of research supported by the program on all sectors of our aging society.

Notice NOT-AG-17-006 from the NIH Guide for Grants and Contracts

Not Specified: Celgene: Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health.  We val Independence, Missouri (US)

Funding Opportunity PAR-17-249 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

As part of the Global Discovery Toxicology Team work in interdisciplinary teams within and across Global Safety Assessment to provide safety support to early...
From Takeda Pharmaceuticals - Tue, 04 Apr 2017 07:09:10 GMT - View all Cambridge jobs

Demonstrated ability to independently develop and implement computational workflows starting from raw data through analysis, hypothesis generation and...
From Takeda Pharmaceuticals - Tue, 04 Apr 2017 07:08:07 GMT - View all Cambridge jobs

The Analytical Science Biostatistics Department of Takeda Company in Deerfield, IL is looking for PhD Graduate students interested in an internship during...
From Takeda Pharmaceuticals - Tue, 04 Apr 2017 07:08:02 GMT - View all Deerfield jobs

Distributed data analysis pipelines across LAN and cloud nodes. Supporting NGS and related bioinformatics software tools and pipelines....
From Roche - Tue, 04 Apr 2017 01:59:58 GMT - View all Santa Clara jobs

Or equivalent experience in computer science, information theory, physics, electrical engineering, computational biology, or statistics.... $150,000 a year
From Enterprise Select - Mon, 03 Apr 2017 19:11:21 GMT - View all Santa Clara jobs

Funding Opportunity PA-17-247 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U18 cooperative agreement applications to stimulate innovative and collaborative research by utilizing new health information technology (IT) strategies for collecting and using patient-reported outcome (PRO) measures in primary care and other ambulatory care settings.